We serve Chemical Name:2,6-Dibromo-4-fluorophenyl isocyanate CAS:76393-18-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2,6-Dibromo-4-fluorophenyl isocyanate
CAS.NO:76393-18-5
Synonyms:MFCD00037041;1,3-dibromo-5-fluoro-2-isocyanatobenzene
Molecular Formula:C7H2Br2FNO
Molecular Weight:294.90300
HS Code:2929109000
Physical and Chemical Properties:
Melting point:42-45ºC
Boiling point:295.5ºC at 760 mmHg
Density:2.01g/cm3
Index of Refraction:1.614
PSA:29.43000
Exact Mass:292.84900
LogP:3.31800
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2811
Packing Group:III
Contact us for information like MFCD00037041 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,3-dibromo-5-fluoro-2-isocyanatobenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00037041 Use and application,MFCD00037041 technical grade,usp/ep/jp grade.
Related News: Therefore, the growth of the global pharmaceutical market has greatly affected the development of the entire intermediate and API industry. 2,6-Dibromo-4-fluorophenyl isocyanate manufacturer In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being. 2,6-Dibromo-4-fluorophenyl isocyanate supplier In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being. 2,6-Dibromo-4-fluorophenyl isocyanate vendor In the context of increasingly tight global productive capacity cooperation in the pharmaceutical industry, some multinational pharmaceutical companies have chosen to abandon their original full industrial chain model and shift their focus to market operations. R & D, clinical, and production links reduce costs through outsourcing. Patented APIs came into being. 2,6-Dibromo-4-fluorophenyl isocyanate factory Johnson & Johnson’s Darzalex has comfortably been the only CD38 multiple myeloma drug on the market for years until Sanofi hit the scene last year with Sarclisa. Now, just as the competition’s slated to intensify, the U.S. company is building its case with new patient survival data.
